These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 400749)

  • 61. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 62. Physiologic definition of blood pressure response to renal revascularization in patients with renovascular hypertension.
    Vaughan ED; Carey RM; Ayers CR; Peach MJ; Tegtmeyer CJ; Wellons HA
    Kidney Int Suppl; 1979 Mar; (9):S83-92. PubMed ID: 289868
    [No Abstract]   [Full Text] [Related]  

  • 63. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 65. [The use of angiotensin II antagonists in the diagnosis of renovascular hypertension].
    Presenti L
    Recenti Prog Med; 1981 Mar; 70(3):315-6. PubMed ID: 7244339
    [No Abstract]   [Full Text] [Related]  

  • 66. Hemodynamic effects of an angiotensin II antagonist in rabbits with perinephritis hypertension.
    Ichikawa S; Johnson JA; Stanton MW; Payne CG; Keitzer WF
    Proc Soc Exp Biol Med; 1977 Jun; 155(2):259-63. PubMed ID: 866354
    [No Abstract]   [Full Text] [Related]  

  • 67. Renal secretion of inactive renin.
    Derkx FH; Verhoeven RP; Wenting GJ; Man in 't Veld AJ; Schalekamp MA
    Contrib Nephrol; 1978; 11():160-3. PubMed ID: 699585
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
    Kreft C; Menard J; Corvol P
    Kidney Int; 1979 Feb; 15(2):176-83. PubMed ID: 513483
    [No Abstract]   [Full Text] [Related]  

  • 70. Negative saralasin response in correctable renovascular hypertension.
    Trainin EB; Lala VR; Gomez-Leon G; AvRuskin TW
    J Pediatr; 1978 Sep; 93(3):460-2. PubMed ID: 690764
    [No Abstract]   [Full Text] [Related]  

  • 71. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 72. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of sodium depletion and angiotensin II antagonism in renal hypertensive rabbits.
    Johnson JA; Stubbs DH; Stanton M; Payne C; Ichikawa S; Keitzer WF
    Am J Physiol; 1977 Oct; 233(4):H514-9. PubMed ID: 910968
    [No Abstract]   [Full Text] [Related]  

  • 75. Intrarenal arterial stenosis. Saralasin acetate infusion test as an aid to diagnosis.
    Doody PT; Wombolt DG; Tynes WV; Goldberg M
    Clin Pediatr (Phila); 1982 Jan; 21(1):32-5. PubMed ID: 7055999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Screening of angiotensin II dependent hypertensive patients using a linear classifier.
    Koivo AJ
    Med Inform (Lond); 1981; 6(1):19-24. PubMed ID: 7015036
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Measurement of plasma renin concentration and angiotensin II in peripheral and renal venous plasma in the management of renovascular hypertension.
    Padfield PL; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Tree M
    Contrib Nephrol; 1976; 3():45-51. PubMed ID: 1026369
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Angiotensin blockade by saralasin bolus injection.
    Maxwell MH; Marks LS
    Kidney Int Suppl; 1979 Mar; (9):S53-9. PubMed ID: 289864
    [No Abstract]   [Full Text] [Related]  

  • 79. Plasma renin activity in renal veins of renovascular patients.
    Salvetti A; Arzilli F; Sassano P; Poli L; Pedrinelli R
    Contrib Nephrol; 1978; 11():150-4. PubMed ID: 699583
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-renin-mediated renovascular hypertension: A new syndrome?
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1977 Mar; 1(8012):615-7. PubMed ID: 66424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.